TITLE

For type 2 diabetes, after metformin, what next?

PUB. DATE
July 2010
SOURCE
Internal Medicine Alert;6/29/2010 Supplement, p96
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers information on the effects of noninsulin antidiabetic drugs added to metformin therapy for patients with type 2 diabetes (DM2).
ACCESSION #
51973953

 

Related Articles

  • Choose metformin in type 2 diabetes.  // Pulse;2/22/2012, Vol. 72 Issue 7, p11 

    The article reports on the suggestion of a U.S. guidelines on choosing metformin as a medicine for type 2 diabetes patients who do not respond to lifestyle modification.

  • Maximize benefits of metform in DM2. Kuritzky, Louis // Primary Care Reports;May2010 Supplement, p9 

    The article discusses research being done on the efficacy of metformin monotherapy in controlling glucose in type 2 diabetes, which references a study by J. B. Brown and colleagues published in a 2010 issue of the journal "Diabetes Care."

  • For type 2 diabetes, after metformin, what next? Kuritzky, Louis // Primary Care Reports;Jul2010 Clinical Briefs, p14 

    The article discusses the therapeutic choices for type-2 diabetes following initial treatment with metformin.

  • Maximize benefits of metform in DM2. Kuritzky, Louis // Neurology Alert;May2010 Pharmacology, p9 

    The article discusses research done on metformin monotherapy and type 2 diabetes mellitus, referencing a study by J. B. Brown et al, published in a 2010 issue of "Diabetes Care."

  • For type 2 diabetes, after metformin, what next? Kuritzky, Louis // Clinical Oncology Alert;Jul2010 Supplement, p14 

    The article discusses the therapeutic choices for type-2 diabetes following initial treatment with metformin.

  • For type 2 diabetes, after metformin, what next? Kuritzky, Louis // Neurology Alert;Jul2010 Primary Care, Vol. 15 Issue 7, p14 

    The article discusses research by O. J. Phung et al on the use metformin in the treatment of patients with type 2 diabetes, published in a 2010 issue of the "Journal of the American Medical Association."

  • Exenatide + rosiglitazone added to metformin.  // Internal Medicine Alert;7/29/2010 Supplement, p112 

    The article reports that initial therapy for type 2 diabetes (DM2) should be mixed with metformin with the add-on therapy of exenatide (EXE) and rosiglitazone (ROS) which are effective therapies for glucose control.

  • Diaphage Tablets.  // South African Family Practice;2014, Vol. 56 Issue 2, p87 

    The article evaluates the Diaphage tablets for Type II diabetes mellitus from Cipla.

  • Metformin showed best results for first-line treatment of type 2 diabetes.  // Endocrine Today;Apr2011, Vol. 9 Issue 4, p32 

    The article discusses research being done on the effectiveness of metformin as a first-line treatment for type 2 diabetes, referencing a study by W. L. Bennett et al, published in a 2011 issue of "Annals of Internal Medicine."

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics